| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |